Chemomab Therapeutics (CMMB) Depreciation and Depletion (2018 - 2023)
Chemomab Therapeutics posted quarterly Depreciation and Depletion of $16000.0 for Q4 2023, up 14.29% year-on-year from $14000.0 in Q4 2022, and down 15.79% on a QoQ basis from $19000.0 in Q3 2023.
Chemomab Therapeutics (CMMB) has 6 years of Depreciation and Depletion data on file, last reported at $16000.0 in Q4 2023.
- For the quarter ending Q4 2023, Depreciation and Depletion rose 14.29% year-over-year to $16000.0; the trailing twelve-month figure through Dec 2023 stood at $67000.0 (up 15.52% YoY), and the FY2025 full-year result was $70000.0, up 32.08% from the prior year.
- Depreciation and Depletion for Q4 2023 stood at $16000.0, down from $19000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $211000.0 in Q4 2019 and bottomed at $5000.0 in Q1 2020.
- The 5-year median for Depreciation and Depletion is $14000.0 (2022), against an average of $23200.0.
- The widest annual swing landed in 2019, when Depreciation and Depletion soared 955.0%; it then tumbled 97.16% in 2020.
- A 5-year view of Depreciation and Depletion shows it stood at $211000.0 in 2019, then sank by 97.16% to $6000.0 in 2020, then soared by 83.33% to $11000.0 in 2021, then grew by 27.27% to $14000.0 in 2022, then rose by 14.29% to $16000.0 in 2023.
- The last three Depreciation and Depletion figures came in at $16000.0 (Q4 2023), $19000.0 (Q3 2023), and $16000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 211,000.00 |
| Dec 31, 2019 | 211,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Dec 31, 2018 | 20,000.00 |
| Dec 31, 2018 | 20,000.00 |
| Sep 30, 2018 | 16,000.00 |
| Sep 30, 2018 | 16,000.00 |